I,like some,have misread the tape on this one:not unusual in...

I,like some,have misread the tape on this one:not unusual in Bio-Tech speculation.Games are being played with the SP,causing mild discomfort.Have to be long here[in hindsight].The health saga in America has implications for the Company.Despite Government claims,Health-Care costs will rise:medical device makers expect this to happen.The cost of additional insurance for 32 million will damage the Health system:companies will not pass on their savings to the consumer.There is 30 trillion in unfunded liabilities ticking away.The investor[i wish I could trade it!],must decide if the glass is half full or empty:Karmelsonix products will become too expensive for health over-counter sales or the 32 million additional insurance will increase opportunities for marketing.
I still am confident that it is the increasing stresses on the health system that may create greater need for outsourcing emergency services such as asthma management.And so we wait....